Want to join the conversation?
Michael Weinstein of JP Morgan asks about unchanged cash flow guidance. CFO James Saccaro said that $BAX didn't change its cash flow guidance as its cash flow is back-end loaded due to normal seasonality patterns. He added that until $BAX gets a better insight on how 3Q and 4Q emerges, it will be premature to raise the cash flow guidance for 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?